These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1430 related articles for article (PubMed ID: 34505819)

  • 1. Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine.
    Koong LR; Chee WK; Toh ZH; Ng XL; Agrawal R; Ho SL
    Ocul Immunol Inflamm; 2021 Aug; 29(6):1212-1215. PubMed ID: 34505819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vogt-Koyanagi-Harada Disease following mRNA-1273 (Moderna) COVID-19 Vaccination.
    Joo CW; Kim YK; Park SP
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1250-1254. PubMed ID: 35404752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vogt-Koyanagi-Harada Disease Exacerbation Associated with COVID-19 Vaccine.
    De Domingo B; López M; Lopez-Valladares M; Ortegon-Aguilar E; Sopeña-Perez-Argüelles B; Gonzalez F
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vogt-Koyanagi-Harada Syndrome following influenza vaccination.
    Kim M
    Indian J Ophthalmol; 2016 Jan; 64(1):98. PubMed ID: 26953036
    [No Abstract]   [Full Text] [Related]  

  • 5. Case report: Bilateral panuveitis resembling Vogt-Koyanagi-Harada disease after second dose of BNT162b2 mRNA COVID-19 vaccine.
    Sato T; Nihei R; Sora D; Nishio Y; Takeuchi M
    Front Immunol; 2022; 13():967972. PubMed ID: 36248859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
    Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
    BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vogt-Koyanagi-Harada disease after stapedotomy.
    Accorinti M; Gilardi M; Nardella C; Amorelli GM; Pesci FR
    Eur J Ophthalmol; 2015 Oct; 25(6):e127-30. PubMed ID: 25982211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vogt-Koyanagi-Harada
    Campos WR; Cenachi SPF; Soares MS; Gonçalves PF; Vasconcelos-Santos DV
    Ocul Immunol Inflamm; 2021 Jan; 29(1):124-127. PubMed ID: 31603703
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
    Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
    Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vogt-Koyanagi-Harada disease following ChAdOx1 nCoV-19 and mRNA-1273 vaccination.
    Rujkorakarn P; Patamatamkul S
    J Fr Ophtalmol; 2023 Mar; 46(3):207-210. PubMed ID: 36775731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease.
    Maruko I; Iida T; Sugano Y; Oyamada H; Sekiryu T; Fujiwara T; Spaide RF
    Retina; 2011 Mar; 31(3):510-7. PubMed ID: 20948460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vogt-Koyanagi-Harada syndrome in a case of multiple sclerosis.
    Montero JA; Sanchis ME; Fernandez-Munoz M
    J Neuroophthalmol; 2007 Mar; 27(1):36-40. PubMed ID: 17414871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible Association between Vogt-Koyanagi-Harada Disease and Coronavirus Disease Vaccine: A Report of Four Cases.
    de Queiroz Tavares Ferreira F; Araújo DC; de Albuquerque LM; Bianchini PM; Holanda EC; Pugliesi A
    Ocul Immunol Inflamm; 2023 Aug; 31(6):1134-1140. PubMed ID: 35914285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical management of a case of non-resolving bullous retinal detachment due to probable Vogt-Koyanagi-Harada syndrome.
    Dutta Majumder P; Shah M; Sen P
    Eur J Ophthalmol; 2024 Jul; 34(4):NP12-NP15. PubMed ID: 38629147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fundus autofluorescence as a marker of disease severity in Vogt-Koyanagi-Harada disease.
    Morita C; Sakata VM; Rodriguez EE; Abdallah SF; Lavezzo MM; da Silva FT; Machado CG; Oyamada MK; Hirata CE; Yamamoto JH
    Acta Ophthalmol; 2016 Dec; 94(8):e820-e821. PubMed ID: 27368955
    [No Abstract]   [Full Text] [Related]  

  • 16. Vogt Koyanagi Harada disease following a recent COVID-19 infection.
    Anthony E; Rajamani A; Baskaran P; Rajendran A
    Indian J Ophthalmol; 2022 Feb; 70(2):670-672. PubMed ID: 35086262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
    Tsui E; Bottini A; Ghadiali Q; Balaratnasingam C; Barbazetto I
    Ocul Immunol Inflamm; 2018; 26(8):1297-1300. PubMed ID: 29020488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vogt-Koyanagi-Harada Syndrome Following COVID-19 mRNA Vaccination: Th2 to Th1 Transition-related Molecular Machinery.
    Ikuno Y; Yamaguchi A; Takahashi T; Fujimoto N
    Acta Derm Venereol; 2024 May; 104():adv21502. PubMed ID: 38738771
    [No Abstract]   [Full Text] [Related]  

  • 19. A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome.
    Zhang Q; Fan X; Tian M; Han H
    BMC Nephrol; 2020 Jul; 21(1):272. PubMed ID: 32660433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vogt-Koyanagi-Harada disease after head trauma.
    Accorinti M; Pirraglia MP; Corsi C; Caggiano C
    Eur J Ophthalmol; 2007; 17(5):847-52. PubMed ID: 17932867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.